Praxis Precision Medicines PRAX
NASDAQ PRAX
$337.59 +4.62 (+1.39%)
At close: Nov 10, 2026 · 4:00 PM EST

Praxis Precision Medicines (PRAX) Revenue (2023 - 2024)

Updated

Analysis

Praxis Precision Medicines (PRAX) Revenue (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 25.40 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 17.40 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 15.38 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 8.30 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 16.58 Bn
10 Praxis Precision Medicines 9.79 Bn 7.38 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 7.46 Mn
Sep 30, 2024 302,000.00
Jun 30, 2024 357,000.00
Mar 31, 2024 431,000.00
Dec 31, 2023 515,000.00
Sep 30, 2023 468,000.00
Jun 30, 2023 781,000.00
Mar 31, 2023 683,000.00
API Access

Praxis Precision Medicines Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PRAX&period=max&api_key=YOUR_API_KEY